Inogen (INGN) Revenue & Revenue Breakdown
Inogen Revenue Highlights
Latest Revenue (Y)
$315.66M
Latest Revenue (Q)
$88.77M
Main Geography (Y)
UNITED STATES
Inogen Revenue by Period
Inogen Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $315.66M | -16.32% |
2022-12-31 | $377.24M | 5.37% |
2021-12-31 | $358.00M | 16.05% |
2020-12-31 | $308.49M | -14.77% |
2019-12-31 | $361.94M | 1.07% |
2018-12-31 | $358.11M | 43.57% |
2017-12-31 | $249.44M | 22.98% |
2016-12-31 | $202.83M | 27.56% |
2015-12-31 | $159.00M | 41.29% |
2014-12-31 | $112.54M | 49.17% |
2013-12-31 | $75.44M | 55.31% |
2012-12-31 | $48.58M | 58.57% |
2011-12-31 | $30.63M | - |
Inogen Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $88.77M | 13.76% |
2024-03-31 | $78.03M | 2.81% |
2023-12-31 | $75.90M | -9.61% |
2023-09-30 | $83.97M | 0.40% |
2023-06-30 | $83.64M | 15.90% |
2023-03-31 | $72.16M | -18.08% |
2022-12-31 | $88.09M | -16.41% |
2022-09-30 | $105.39M | 1.95% |
2022-06-30 | $103.38M | 28.60% |
2022-03-31 | $80.39M | 5.21% |
2021-12-31 | $76.40M | -17.94% |
2021-09-30 | $93.11M | -8.33% |
2021-06-30 | $101.56M | 16.83% |
2021-03-31 | $86.93M | 17.51% |
2020-12-31 | $73.98M | -0.47% |
2020-09-30 | $74.33M | 3.68% |
2020-06-30 | $71.69M | -18.98% |
2020-03-31 | $88.49M | 12.13% |
2019-12-31 | $78.92M | -14.00% |
2019-09-30 | $91.76M | -9.20% |
2019-06-30 | $101.06M | 12.04% |
2019-03-31 | $90.20M | 4.24% |
2018-12-31 | $86.53M | -9.19% |
2018-09-30 | $95.29M | -2.00% |
2018-06-30 | $97.24M | 23.01% |
2018-03-31 | $79.05M | 23.93% |
2017-12-31 | $63.79M | -7.60% |
2017-09-30 | $69.03M | 7.66% |
2017-06-30 | $64.12M | 22.14% |
2017-03-31 | $52.50M | 3.24% |
2016-12-31 | $50.85M | -6.56% |
2016-09-30 | $54.42M | -0.27% |
2016-06-30 | $54.57M | 26.93% |
2016-03-31 | $42.99M | 6.29% |
2015-12-31 | $40.45M | -0.81% |
2015-09-30 | $40.78M | -7.38% |
2015-06-30 | $44.03M | 30.45% |
2015-03-31 | $33.75M | 15.91% |
2014-12-31 | $29.12M | -0.94% |
2014-09-30 | $29.39M | -3.29% |
2014-06-30 | $30.39M | 28.60% |
2014-03-31 | $23.63M | 19.59% |
2013-12-31 | $19.76M | -0.08% |
2013-09-30 | $19.78M | -1.89% |
2013-06-30 | $20.16M | 28.01% |
2013-03-31 | $15.75M | 13.77% |
2012-12-31 | $13.84M | - |
Inogen Revenue Breakdown
Inogen Revenue Breakdown by Product
Quarterly Revenue by Product
Product/Service | Mar 18 |
---|---|
Lifetime Warranties | $11.99M |
Inogen Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
Non-US | $89.40M | $101.16M | - | - | - |
UNITED STATES | $226.26M | $276.08M | $278.54M | $246.34M | $283.98M |
Non Us | - | - | $79.46M | $62.15M | $77.96M |
Quarterly Revenue by Country
Country | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Non-US | $26.04M | $21.52M | $25.61M | $23.29M | $18.97M | $20.70M | $15.08M | $37.44M | - | - | - | - | - | - | - | - | - | - | - | - |
UNITED STATES | $51.99M | $54.37M | $58.35M | $60.34M | $53.19M | $67.39M | $90.31M | $65.94M | $52.44M | $56.32M | $79.74M | $71.21M | $60.37M | $59.75M | $57.82M | $68.41M | $61.82M | $73.27M | $78.50M | - |
Non Us | - | - | - | - | - | - | - | - | $27.94M | $20.08M | $21.83M | $21.82M | $15.72M | $13.61M | $14.58M | $13.87M | $20.08M | $17.10M | $18.49M | $22.56M |
U S | - | - | - | - | - | - | - | - | - | - | $71.27M | - | - | - | - | - | - | - | - | - |
Inogen Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ITGR | Integer | $1.60B | $746.27M |
CNMD | CONMED | $1.24B | $316.70M |
AORT | Artivion | $354.00M | $98.02M |
INGN | Inogen | $315.66M | $88.77M |
KIDS | OrthoPediatrics | $148.73M | $52.80M |
SIBN | SI-BONE | $138.89M | $39.97M |
SRDX | Surmodics | $132.58M | $30.34M |
SGHT | Sight Sciences | $81.06M | $21.37M |
LUNG | Pulmonx | $68.67M | $20.39M |
NPCE | NeuroPace | $65.42M | $18.12M |
APYX | Apyx Medical | $52.35M | $12.15M |
CVRX | CVRx | $39.30M | $13.37M |
OFIX | Orthofix Medical | $100.00K | $198.62M |
INGN Revenue FAQ
What is Inogen’s yearly revenue?
Inogen's yearly revenue for 2023 was $315.66M, representing a decrease of -16.32% compared to 2022. The company's yearly revenue for 2022 was $377.24M, representing an increase of 5.37% compared to 2021. INGN's yearly revenue for 2021 was $358M, representing an increase of 16.05% compared to 2020.
What is Inogen’s quarterly revenue?
Inogen's quarterly revenue for Q2 2024 was $88.76M, a 13.76% increase from the previous quarter (Q1 2024), and a 6.13% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $78.02M, a 2.81% increase from the previous quarter (Q4 2023), and a 8.12% increase year-over-year (Q1 2023). INGN's quarterly revenue for Q4 2023 was $75.9M, a -9.61% decrease from the previous quarter (Q3 2023), and a -13.84% decrease year-over-year (Q4 2022).
What is Inogen’s revenue growth rate?
Inogen's revenue growth rate for the last 3 years (2021-2023) was -11.83%, and for the last 5 years (2019-2023) was -12.79%.